Lv0
0 积分 2023-12-02 加入
Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma
3个月前
已完结
Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy
3个月前
已完结
Rethinking ovarian cancer III: the past decade and future directions
3个月前
已完结
Advancing targeted protein degradation for cancer therapy
3个月前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
4个月前
已完结
EP-0108A is a moderation selectively BRD4 BD2 inhibitor with potential AML tumor suppression
5个月前
已关闭
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway
5个月前
已完结
Acute myeloid leukaemia
6个月前
已关闭
Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma
9个月前
已完结
Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders
10个月前
已完结
皖公网安备34019202002308
